Atypical mucocutaneous leishmaniasis caused by Leishmania braziliensis in an acquired immunodeficiency syndrome patient: T-cell responses and remission of lesions associated with antigen immunotherapy - PubMed (original) (raw)
Atypical mucocutaneous leishmaniasis caused by Leishmania braziliensis in an acquired immunodeficiency syndrome patient: T-cell responses and remission of lesions associated with antigen immunotherapy
A M Da-Cruz et al. Mem Inst Oswaldo Cruz. 1999 Jul-Aug.
Free article
Abstract
An atypical case of acquired immunodeficiency syndrome-associated mucocutaneous lesions due to Leishmania braziliensis is described. Many vacuolated macrophages laden with amastigote forms of the parasite were found in the lesions. Leishmanin skin test and serology for leishmaniasis were both negative. The patient was resistant to therapy with conventional drugs (antimonial and amphotericin B). Interestingly, remission of lesions was achieved after an alternative combined therapy of antimonial associated with immunotherapy (whole promastigote antigens). Peripheral blood mononuclear cells were separated and stimulated in vitro with Leishmania antigens to test the lymphoproliferative responses (LPR). Before the combined immunochemotherapy, the LPR to leishmanial antigens was negligible (stimulation index - SI=1.4). After the first course of combined therapy it became positive (SI=4.17). The antigen responding cells were predominantly T-cells (47.5%) most of them with CD8+ phenotype (33%). Very low CD4+ cells (2.2%) percentages were detected. The increased T-cell responsiveness to leishmanial antigens after combined therapy was accompanied by interferon-g (IFN-g) production as observed in the cell culture supernatants. In this patient, healing of the leishmaniasis lesions was associated with the induction of a specific T-cell immune response, characterized by the production of IFN-g and the predominance of the CD8+ phenotype among the Leishmania-reactive T-cells.
Similar articles
- T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure.
Coutinho SG, Oliveira MP, Da-Cruz AM, De Luca PM, Mendonça SC, Bertho AL, Soong L, McMahon-Pratt D. Coutinho SG, et al. Exp Parasitol. 1996 Nov;84(2):144-55. doi: 10.1006/expr.1996.0100. Exp Parasitol. 1996. PMID: 8932764 - Flow cytometric analysis of cellular infiltrate from American tegumentary leishmaniasis lesions.
Da-Cruz AM, Bertho AL, Oliveira-Neto MP, Coutinho SG. Da-Cruz AM, et al. Br J Dermatol. 2005 Sep;153(3):537-43. doi: 10.1111/j.1365-2133.2005.06647.x. Br J Dermatol. 2005. PMID: 16120139 - Parasitological and immunological follow-up of American tegumentary leishmaniasis patients.
Coutinho SG, Pirmez C, Da-Cruz AM. Coutinho SG, et al. Trans R Soc Trop Med Hyg. 2002 Apr;96 Suppl 1:S173-8. doi: 10.1016/s0035-9203(02)90072-6. Trans R Soc Trop Med Hyg. 2002. PMID: 12055834 - Disseminated American muco-cutaneous leishmaniasis caused by Leishmania braziliensis braziliensis in a patient with AIDS: a case report.
Machado ES, Braga Mda P, Da Cruz AM, Coutinho SG, Vieira AR, Rutowitsch MS, Cuzzi-Maya T, Grimaldi júnior G, Menezes JA. Machado ES, et al. Mem Inst Oswaldo Cruz. 1992 Oct-Dec;87(4):487-92. doi: 10.1590/s0074-02761992000400005. Mem Inst Oswaldo Cruz. 1992. PMID: 1343662 Review. - [Immunopathology of American tegumentary leishmaniasis].
Castés M, Tapia FJ. Castés M, et al. Acta Cient Venez. 1998;49(1):42-56. Acta Cient Venez. 1998. PMID: 10205916 Review. Spanish.
Cited by
- Characterization of Differentially Abundant Proteins Among Leishmania (Viannia) braziliensis Strains Isolated From Atypical or Typical Lesions.
Esteves BB, Melo-Braga MN, Gorshkov V, Verano-Braga T, Larsen MR, Gontijo CMF, Quaresma PF, Andrade HM. Esteves BB, et al. Front Cell Infect Microbiol. 2022 Feb 15;12:824968. doi: 10.3389/fcimb.2022.824968. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35242720 Free PMC article. - Comparative proteomic analysis of Leishmania parasites isolated from visceral and cutaneous leishmaniasis patients.
Dinç M, Yalçın T, Çavuş İ, Özbilgin A. Dinç M, et al. Parasitology. 2022 Mar;149(3):298-305. doi: 10.1017/S0031182021001967. Epub 2021 Nov 11. Parasitology. 2022. PMID: 34758895 Free PMC article. - Diabetes Modifies the Clinic Presentation of Cutaneous Leishmaniasis.
Lago AS, Lima FR, Carvalho AM, Sampaio C, Lago N, Guimarães LH, Lago J, Machado PRL, Carvalho LP, Arruda S, Carvalho EM. Lago AS, et al. Open Forum Infect Dis. 2020 Oct 19;7(12):ofaa491. doi: 10.1093/ofid/ofaa491. eCollection 2020 Dec. Open Forum Infect Dis. 2020. PMID: 33324720 Free PMC article. - Protective Cellular Immune Response Induction for Cutaneous Leishmaniasis by a New Immunochemotherapy Schedule.
da Silva DAM, Santana FR, Katz S, Garcia DM, Teixeira D, Longo-Maugéri IM, Barbiéri CL. da Silva DAM, et al. Front Immunol. 2020 Mar 3;11:345. doi: 10.3389/fimmu.2020.00345. eCollection 2020. Front Immunol. 2020. PMID: 32194563 Free PMC article. - Atypical Manifestations of Cutaneous Leishmaniasis in a Region Endemic for Leishmania braziliensis: Clinical, Immunological and Parasitological Aspects.
Guimarães LH, Queiroz A, Silva JA, Silva SC, Magalhães V, Lago EL, Machado PR, Bacellar O, Wilson ME, Beverley SM, Carvalho EM, Schriefer A. Guimarães LH, et al. PLoS Negl Trop Dis. 2016 Dec 1;10(12):e0005100. doi: 10.1371/journal.pntd.0005100. eCollection 2016 Dec. PLoS Negl Trop Dis. 2016. PMID: 27906988 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials